We work with key partners to advance our understanding of how the CNS will impact and be effected by cure strategies. Projects are managed by a leadership team comprised of Principal Investigators at the U.S. Military HIV Research Program and Yale University.
Leadership
Serena Spudich, MD
Dr. Spudich is a neurologist whose clinical and translational research is focused on the pathogenesis of HIV in the nervous system, in particular the impact of acute HIV infection and early treatment on the central nervous system and the establishment of persistent CNS reservoirs for HIV. Dr. Spudich graduated from medical school at the University of California, San Francisco in 1997, then pursued residency training at the University of Washington in Internal Medicine and at the Massachusetts General Hospital/Brigham and Women’s Hospital combined program in Neurology. She returned to UCSF in 2003 as a fellow in NeuroHIV with Dr. Richard Price, remaining at UCSF until moving to Yale University in 2010 where she is currently the Gilbert H. Glaser Professor of Neurology. She is active in the AIDS Clinical Trials Group, recently serving as Chair of the Neurology Collaborative Science Group and as a member of the HIV Cure committee. She has collaborated with the co-directors and other INHCC investigators in SEARCH-based studies since 2010. In addition to her research, Dr. Spudich cares for people living with HIV with neurological disorders at the Nathan Smith HIV Clinic at Yale.
Dr. Spudich is a neurologist whose clinical and translational research is focused on the pathogenesis of HIV in the nervous system, in particular the impact of acute HIV infection and early treatment on the central nervous system and the establishment of persistent CNS reservoirs for HIV. Dr. Spudich graduated from medical school at the University of California, San Francisco in 1997, then pursued residency training at the University of Washington in Internal Medicine and at the Massachusetts General Hospital/Brigham and Women’s Hospital combined program in Neurology. She returned to UCSF in 2003 as a fellow in NeuroHIV with Dr. Richard Price, remaining at UCSF until moving to Yale University in 2010 where she is currently the Gilbert H. Glaser Professor of Neurology. She is active in the AIDS Clinical Trials Group, recently serving as Chair of the Neurology Collaborative Science Group and as a member of the HIV Cure committee. She has collaborated with the co-directors and other INHCC investigators in SEARCH-based studies since 2010. In addition to her research, Dr. Spudich cares for people living with HIV with neurological disorders at the Nathan Smith HIV Clinic at Yale.
Lydie Trautmann, EngD, PhD
Dr. Trautmann is Director of Translational Research, Global Infectious Diseases Portfolio, at the Henry M Jackson Foundation for the Advancement of Military Medicine in support of MHRP, EIDB, and DCB. She oversees the research efforts in the current and upcoming MHRP clinical trials in Thailand. Dr. Trautmann received her M.Sc. and Engineer Doctor degree in 1998, and her Ph.D. in Immunology at Paris V University in 2003. Prior to her role at HJF, she performed research for two decades in translational human immunology evaluating early treatment, HIV-associated neurocognition and immune interventions aimed at achieving HIV remission at the Vaccine and Gene Therapy Institute in Florida and at the Oregon Health and Science University as well as at MHRP. She has established a strong research agenda with high ranked publications, a large collaborative network and a vigorous funding portfolio. She also serves on several national and international review committees and co-leads the International NeuroHIV Cure Consortium.
Dr. Trautmann is Director of Translational Research, Global Infectious Diseases Portfolio, at the Henry M Jackson Foundation for the Advancement of Military Medicine in support of MHRP, EIDB, and DCB. She oversees the research efforts in the current and upcoming MHRP clinical trials in Thailand. Dr. Trautmann received her M.Sc. and Engineer Doctor degree in 1998, and her Ph.D. in Immunology at Paris V University in 2003. Prior to her role at HJF, she performed research for two decades in translational human immunology evaluating early treatment, HIV-associated neurocognition and immune interventions aimed at achieving HIV remission at the Vaccine and Gene Therapy Institute in Florida and at the Oregon Health and Science University as well as at MHRP. She has established a strong research agenda with high ranked publications, a large collaborative network and a vigorous funding portfolio. She also serves on several national and international review committees and co-leads the International NeuroHIV Cure Consortium.
